Automatic analyzer and measuring method using the same

The automatic analyzer addresses the issue of reagent deterioration during standby times by determining electrolyte concentration using an ion-selective electrode method and controlling reagent replacement, enhancing measurement reliability by reducing ion measurement variations.

WO2024247515A1PCT designated stage expired Publication Date: 2024-12-05HITACHI HIGH TECH CORP
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/015047
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-30
Filing Date
2024-04-15
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Automatic analyzers in hospital laboratories face challenges in detecting reagent deterioration during standby times, leading to unreliable measurement results due to residual reagents in the flow path, which are not addressed by existing methods that only detect abnormalities at calibration times.

Method used

An automatic analyzer with an electrolyte analysis section using an ion-selective electrode method and a control section that determines reagent deterioration before patient sample measurement, by measuring quality control samples with varying standby times to establish a predetermined time threshold for reagent replacement, ensuring accurate chloride ion concentration measurements.

Benefits of technology

This approach improves the reliability of measurement results by detecting and addressing reagent deterioration during standby times, reducing variations in ion measurements and maintaining accurate electrolyte concentration analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024015047_05122024_PF_FP_ABST
    Figure JP2024015047_05122024_PF_FP_ABST
Patent Text Reader

Abstract

In the prior art, the reliability of a measurement result is lowered by the deterioration of an ISE reagent remaining in a flow passage in the standby time of an electrolyte analysis unit. To solve this problem, when receiving an instruction to measure a patient sample requiring measurement using an electrolyte analysis unit 8, this automatic analysis device 1 determines deterioration of a residual reagent remaining in the flow path of the electrolyte analysis unit prior to measurement of the patient sample when the standby time of the electrolyte analysis unit is equal to or greater than a predetermined time.
Need to check novelty before this filing date? Find Prior Art

Description

Automated analyzer and measurement method using same

[0001] The present invention relates to an automatic analyzer that performs qualitative and quantitative analysis of components of blood, urine, etc. collected from patient specimens, and a measurement method using the same.

[0002] Automated analyzers are used in hospital laboratories and testing centers. In emergency situations, specimen testing in hospital laboratories must be initiated quickly, even during surgery, at night, or on holidays, while still providing measurement results as reliable as those for regular testing. Automated analyzers have a colorimetric analysis unit and an electrolyte analysis unit. The electrolyte analysis unit, which uses the ion-selective electrode method, uses three types of reagents (hereinafter referred to as ISE reagents): an internal standard solution, a diluent, and a reference electrode solution. Therefore, if the ISE reagent has deteriorated, accurate measurement results cannot be obtained. Generally, reagent deterioration occurs gradually from day to day, resulting in slight variations that are difficult to detect. Patent Document 1 discloses a method for detecting abnormal measurement values ​​due to reagent deterioration based on the pattern of daily calibration result fluctuations (over approximately one month).

[0003] JP 2013-213841 A

[0004] The technology in Patent Document 1 can only detect abnormalities at the timing of calibration. Furthermore, it detects abnormalities from fluctuation patterns, and does not take into account the deterioration of the ISE reagent (referred to as a residual reagent) remaining in the flow path that occurs during standby time of the device. The object of the present invention is to detect the deterioration of the residual reagent that occurs during standby time of the device and improve the reliability of the measurement results of an automatic analyzer.

[0005] An automated analyzer according to one embodiment of the present invention comprises an electrolyte analysis unit that measures electrolyte concentrations using an ion selective electrode method and is capable of measuring at least chloride ion concentration, and a control unit, and when the control unit receives a measurement instruction for a patient sample that requires measurement using the electrolyte analysis unit, if the standby time of the electrolyte analysis unit is equal to or longer than a predetermined time, the control unit determines whether any residual reagent remaining in the flow path of the electrolyte analysis unit has deteriorated prior to measuring the patient sample.

[0006] If the standby time of the electrolyte analyzer is longer than a predetermined time, the deterioration of the remaining reagent is determined before measuring the patient's sample, thereby eliminating abnormal measurement values ​​due to deterioration of the ISE reagent in the flow path and improving the reliability of the measurement results. Other objects and novel features will become apparent from the description of this specification and the accompanying drawings.

[0007] FIG. 1 is a hardware configuration diagram of an automatic analyzer. FIG. 2 is a schematic configuration diagram of an electrolyte analysis unit. FIG. 3 is a diagram showing the results of continuous measurement of a quality control sample with a standby time of 0 hours. FIG. 4 is a diagram showing the results of continuous measurement of a quality control sample with a standby time of 2 hours. FIG. 5 is a diagram showing the results of continuous measurement of a quality control sample with a standby time of 5 hours. FIG. 6 is a diagram showing the results of continuous measurement of a quality control sample with a standby time of 17 hours. FIG. 7 is a sample measurement flowchart of the electrolyte analysis unit. FIG. 8 is a flowchart for determining deterioration of an ISE reagent. FIG. 9 is a diagram for explaining a method for determining a predetermined time X, which is the implementation standard for determining deterioration of an ISE reagent. FIG. 10 is a details of the flowchart for determining deterioration of an ISE reagent in Example 1. FIG. 11 is an example screen for determining deterioration of an ISE reagent in Example 1. FIG. 12 is a details of the flowchart for determining deterioration of an ISE reagent in Example 2. FIG. 13 is an example screen for determining deterioration of an ISE reagent in Example 2.

[0008] The embodiments of the present invention will be described in detail with reference to the drawings. In the following embodiments, it goes without saying that the components (including element steps, etc.) are not necessarily essential unless otherwise specified or considered to be obviously essential in principle.

[0009] The overall configuration of the automatic analyzer of this embodiment will be described with reference to Fig. 1. Fig. 1 is a hardware configuration diagram showing the overall configuration of the automatic analyzer.

[0010] The automated analyzer 1 is a specimen testing device that automatically analyzes specimens collected from patients. The automated analyzer 1 is equipped with a mechanism for dispensing and reacting a fixed amount of patient specimen with a reagent using a sample dispensing mechanism 7 and a reagent dispensing mechanism 6. Here, a disk-type automated analyzer will be described as an example, but the present invention is not limited to this and may also be used with a rack-type analyzer, for example.

[0011] The automated analyzer 1 includes a colorimetric analysis unit and an electrolyte analysis unit. The colorimetric analysis unit primarily includes a sample disk 2 on which a sample cup 3 containing a sample is mounted and which rotates a disk-shaped table to move a desired sample to a sampling position; a reagent disk 4 on which reagent bottles containing reaction reagents are mounted and which rotates to move a desired reagent to a dispensing position; reaction vessels 5, which are maintained at a constant temperature by constant-temperature water and each allow a predetermined amount of dispensed patient sample to react with the reagent; a reagent dispensing mechanism 6 that dispenses a predetermined amount of reagent from the reagent bottle into the reaction vessel 5; a sample dispensing mechanism 7 that dispenses a predetermined amount of sample from the sample cup 3 into the reaction vessel 5; and a photometer 13 that measures the progress of the chemical reaction between the sample and the reagent by absorptiometry. The electrolyte analysis unit 8 measures electrolyte concentrations by an ion-selective electrode method using electrodes that selectively respond to specific ions.

[0012] A computer (controller) 10 is connected to each mechanism of the automatic analyzer 1 via an interface 9. The computer 10 controls each mechanism, and measurement results obtained in each analytical section are input to the computer 10. The computer 10 calculates the sample concentration from the measurement results and outputs the obtained sample concentration to a printer 11 or a monitor 12.

[0013] FIG. 2 is a configuration diagram of an electrolyte analysis unit 8 that uses the ion selective electrode method. The overall configuration of the electrolyte analysis unit 8 will be described using FIG. 2. The electrolyte analysis unit 8 includes ion selective electrodes equipped with sensitive membranes for target ions, specifically, a Na (sodium) ion electrode 21, a K (potassium) ion electrode 20, and a Cl (chloride) ion electrode 19, a reference electrode 23, and a potentiometer 15 that measures the potential difference between each of the ion selective electrodes 19-21 and the reference electrode 23. A sipper syringe 26 is used to draw a sample or reagent into the ion selective electrode or the reference electrode. By switching the flow path using a pinch valve 22, the sample or reagent is drawn into either the ion selective electrode or the reference electrode 23.

[0014] The basic operation of the ion selective electrode method is to measure the internal standard solution 16, measure the sample, and measure the internal standard solution 16 again as one set, and the concentrations of Na ions, K ions, and Cl ions can be measured all at once in one measurement.

[0015] In measuring the internal standard solution 16, after the internal standard solution 16 is discharged into the dilution tank 18, the internal standard solution 16 is drawn into the ion selective electrodes 19 to 21, while the reference electrode solution 24 is drawn into the reference electrode 23, and the potential difference between each of the ion selective electrodes 19 to 21 and the reference electrode 23 is measured with the potentiometer 15. In this way, the electromotive forces of the ion selective electrodes 19 to 21 corrected for the internal standard solution 16 are measured. The reference electrode solution 24 has air bubbles removed in a degassing tank 25 before being drawn into the reference electrode 23.

[0016] In measuring a sample, a fixed amount of sample is dispensed from the sample cup 3 into the dilution tank 18 by the sample dispensing mechanism 7, while a fixed amount of diluent 17 is discharged into the dilution tank 18 to dilute the sample to a fixed ratio. The diluent 17 is discharged into the dilution tank 18 after air bubbles are removed in a degassing tank 25. Thereafter, the diluted sample is drawn into the ion selective electrodes 19-21, while the reference electrode solution 24 is drawn into the reference electrode 23, and the potential difference between each of the ion selective electrodes 19-21 and the reference electrode 23 is measured by the potentiometer 15. As a result, the electromotive force of each of the ion selective electrodes 19-21, which has been corrected for electromotive force, is measured for the diluted sample.

[0017] The concentration of the diluted sample can be calculated based on the difference between the electromotive forces of the ion selective electrodes 19-21 measured for the internal standard solution 16 and the electromotive forces of the ion selective electrodes 19-21 measured for the diluted sample. This concentration calculation is performed by the electrolyte concentration calculation unit 14 of the computer 10. The electrolyte concentration calculation unit 14 can be implemented as software using an electrolyte concentration calculation program that can be executed by the computer 10 and that calculates the electrolyte concentration from the potential difference.

[0018] In this way, the ion selective electrode method uses ISE reagents (internal standard solution 16, diluent 17, and reference electrode solution 24) to calculate concentrations. In addition, due to the structure of the electrolyte analysis unit 8, the internal standard solution 16 and diluent 17 are discharged into the dilution tank 18 through the flow paths, and the reference electrode solution 24 is drawn into the reference electrode 23 through the flow path, so that the ISE reagents are always kept filled in the respective flow paths.

[0019] Deterioration of the ISE reagent in the flow path will be explained using Figures 3 to 6. Figures 3 to 6 show the results of continuous Cl ion measurements of 50 quality control samples after the electrolyte analyzer 8 was placed on standby for a predetermined period of time. The standby times in Figures 3 to 6 are 0, 2, 5, and 17 hours, respectively. The standby time here refers to the time from reagent priming in the electrolyte analyzer 8 to the start of this continuous measurement. Reagent priming is a process in which ISE reagent is supplied from each ISE reagent bottle to each flow path, replacing any ISE reagent remaining in the flow path with the ISE reagent from each ISE reagent bottle.

[0020] Comparing these measurement results, we observed an increase in the amount of fluctuation in the Cl ion measurement values ​​as the waiting time increased. Specifically, in the first half of the continuous measurements, the longer the waiting time, the more pronounced the mountain-shaped fluctuation in the measurement values ​​became, while in the second half of the continuous measurements, the variance in the measurement values ​​decreased. This fluctuation is thought to be due to the Cl ion electrode responding to components resulting from the deterioration of the ISE reagent remaining in the flow path. The Cl ion electrode 19 responds not only to Cl ions but also to other ions (called interfering ions) with properties similar to Cl ions. Therefore, when interfering ions are generated due to the deterioration of the ISE reagent, the Cl ion measurement value increases. Even if the deterioration of the ISE reagent progresses equally in the bottle and in the flow path, the interfering ions generated in the relatively small amount of ISE reagent remaining in the flow path will have a relatively high concentration. The gradual increase in the Cl ion measurement values ​​in Figures 5 and 6 is thought to be due to a concentration gradient of components resulting from the deterioration of the remaining reagent in the flow path. The Cl ion measurement value stabilizes when the deteriorated ISE reagent in the flow path is replaced by the ISE reagent from the bottle. The timing at which the measured value gradually rises and peaks varies depending on the flow path volume and therefore differs for each model. Such fluctuations in the ion measured value are not observed for Na ions and K ions.

[0021] Therefore, in this embodiment, if the waiting time exceeds a predetermined time, the flow path confirmation sample is measured in the electrolyte analysis unit before measuring the patient sample (Example 1), or the components resulting from deterioration of the ISE reagent are measured in the colorimetric analysis unit (Example 2) to determine whether the remaining reagent has deteriorated, and the type of maintenance to be performed is selected on the device side based on the determination result and notified to the user.

[0022] 7, the sample measurement operation of the electrolyte analysis unit 8 will be described. Each step is controlled by the computer 10.

[0023] S01: The user starts up the automatic analyzer 1. When the user inputs a start-up instruction into the computer 10, each mechanism including the electrolyte analysis unit 8 is started up via the interface 9.

[0024] S02: Initialization begins. The details of the initial operation are set in advance by the user. In the case of the electrolyte analysis unit 8, this usually includes cleaning of the mechanisms that make up the electrolyte analysis unit 8 and reagent priming, which replaces the ISE reagent in the flow path with a new reagent from a bottle.

[0025] S03-S04: Wait until a patient sample measurement instruction that includes electrolyte analysis as a measurement item is received. When a patient sample measurement instruction (S04) is received from the computer 10, the standby state (S03) ends and the process proceeds to step S05.

[0026] S05: In this embodiment, prior to starting the electrolyte analysis after receiving the patient sample measurement instruction (S04), an ISE reagent deterioration determination is performed. This will be described in detail later. In the following steps S06 to S09, the electrolyte analyzer 8 performs the electrolyte analysis of the patient sample, specifically as follows.

[0027] S06: With the pinch valve 22 closed, the comparison electrode solution 24 is sucked into the comparison electrode 23 by the sipper syringe 26. At this time, the comparison electrode solution 24 is degassed by passing through the degassing tank 25. Meanwhile, the internal standard solution 16 is discharged into the dilution tank 18, and with the pinch valve 22 open, the internal standard solution 16 in the dilution tank 18 is sucked into the Cl ion electrode 19, K ion electrode 20, and Na ion electrode 21 by the sipper syringe 26. The residual solution remaining in the dilution tank 18 is sucked and discarded by a vacuum nozzle (not shown). Thereafter, the potential difference (electromotive force) between the internal standard solution 16 and the comparison electrode solution 24 is measured by the potentiometer 15.

[0028] S07: After dispensing the patient sample into the dilution tank 18 and discharging the dilution solution 17, the solution is stirred to mix. At this time, the dilution solution 17 is degassed by passing it through the degassing tank 25. Subsequently, the diluted sample is measured in the same manner as in step S06. That is, with the pinch valve 22 closed, the reference electrode solution 24 is aspirated into the reference electrode 23 by the sipper syringe 26. Meanwhile, with the pinch valve 22 open, the sipper syringe 26 aspirates the diluted sample from the dilution tank 18 to the Cl ion electrode 19, K ion electrode 20, and Na ion electrode 21. The potential difference (electromotive force) between the diluted sample and the reference electrode solution 24 is then measured by the potentiometer 15. The remaining solution in the dilution tank 18 is aspirated and discarded by the vacuum nozzle.

[0029] Although this flow describes the measurement of patient samples, the standard solutions used for calibration and the quality control samples used for quality control of measurements are also measured in the same manner as described here.

[0030] S08: The dilution tank 18 is cleaned.

[0031] S09: Measure the internal standard solution 16 in the same manner as in S06. If measurement instructions are continuous, return to step S07 and measure the patient sample. In this way, by performing continuous measurements by looping steps S07 to S09, the last measurement can be completed with the measurement of the internal standard solution. As a result, it is possible to transition to a standby state with the flow path from the dilution tank 18 to the ion selective electrode filled with the internal standard solution 16.

[0032] S10: The potential difference measured by the potentiometer 15 is input to the computer 10 via the interface 9, and the computer 10 calculates the electrolyte concentration of the patient sample based on the measurement results of the internal standard solution and the patient sample. The obtained concentration is output to the printer 11 or the monitor 12. When continuous measurements are being performed, the processing of step S10 can be performed in parallel with the measurement by the electrolyte analyzer 8.

[0033] S11: The electrolyte analyzing section 8 automatically stops and goes into a standby state (S03).

[0034] 8 shows a flowchart for determining deterioration of the ISE reagent according to Example 1. This corresponds to the processing of step S05 in the flowchart of FIG.

[0035] S21: The computer 10 measures the standby time of the electrolyte analyzer 8. Specifically, this is the time from the end of the initial operation (S02) until the patient sample measurement instruction (S04) is received, or from the automatic stop (S11) until the patient sample measurement instruction (S04) is received.

[0036] S22: If the waiting time measured in step S21 is equal to or longer than the predetermined time X (YES), proceed to step S23; if it is shorter than the predetermined time X (NO), proceed to step S06 (measurement of internal standard solution) to perform electrolyte analysis of the patient sample.

[0037] S23: Measurement is carried out to determine the deterioration of the ISE reagent.

[0038] S24: The computer 10 determines whether the ISE reagent has deteriorated based on the measurement results for determining deterioration of the ISE reagent. If it determines that the ISE has deteriorated (YES), the computer 10 proceeds to maintenance selection (S25). If it determines that the ISE reagent has not deteriorated (NO), the computer 10 proceeds to step S06 (measurement of the internal standard solution) to perform electrolyte analysis of the patient sample. Details of steps S23 to S25 will be described later.

[0039] Next, an example of how to determine the length of the predetermined time X in step S22 will be described using FIG. 9 . Here, a method will be described in which a predetermined number of quality control samples are measured for different waiting times, as shown in FIGS. 3 to 6 , and the predetermined time X is determined from the measurement results. The horizontal axis of the graph in FIG. 9 represents waiting time, and the vertical axis represents the amount of fluctuation in Cl ion measurement values. The amount of fluctuation in Cl ion measurement values ​​is taken as the amount of change or rate of change in the Cl ion concentration measurement results from continuous measurements (the amount of change and rate of change will be described later). The variance in the amount of fluctuation in Cl ion measurement values ​​is also calculated. The variance CI can be calculated using the standard deviation SD as follows: CI = ±3SD (99.7% confidence interval). For example, in FIG. 9 , the amount of fluctuation for waiting times of 1 to 3 hours is lower than the amount of fluctuation + CI for waiting times of 0 hours, so it can be determined that there is no degradation. On the other hand, the amount of fluctuation for waiting times of 4 to 5 hours is higher than the amount of fluctuation + CI for waiting times of 0 hours, so it can be determined that there is degradation. Based on this, the predetermined time X can be determined to be 3 hours.

[0040] Next, steps S23 to S25 will be described in detail with reference to Fig. 10. Step S31 corresponds to step S23 in the flow of Fig. 8, steps S32 to S35 correspond to step S24 in the flow of Fig. 8, and steps S36 and S37 correspond to step S25 in the flow of Fig. 8.

[0041] S31: The electrolyte analyzer 8 measures the Cl ion concentration of the flow path confirmation sample a predetermined number of times. The predetermined number of times must be at least three, and is determined by the user based on the type of fluctuation to be monitored and the model of the device. The type of flow path confirmation sample is not limited as long as it is within the measurable concentration range specified by the device. Furthermore, although the same sample must be continuously measured, it is acceptable to continuously measure different samples for each run.

[0042] S32: Calculate the amount of fluctuation in the Cl ion measurement value used to determine deterioration of the ISE reagent. The amount of fluctuation can be the amount of change or rate of change in the measurement results of continuously measured Cl ion concentration.

[0043] The amount of change will now be described. Here, the amount of change refers to the difference between the measurement value of a specified sample and the measurement value of the first sample among the measurements of consecutive samples. In this case, it is advisable to specify the sample most affected by ISE reagent deterioration. The position of the sample most affected by ISE reagent deterioration varies depending on the model. For example, in the case of Figure 6, the position of the sample most affected by ISE reagent deterioration is the 13th sample. Therefore, if the predetermined number of times (S31) is set to 13 and the 13th sample is specified as the sample for which the amount of change is to be calculated, the amount of change is the difference between the measurement value of the 13th sample (107.3 mmol / L) and the measurement value of the first sample (102.2 mmol / L), resulting in a change of 5.1 mmol / L.

[0044] Next, the rate of change will be described. Here, the rate of change refers to the slope obtained by first-order approximation of the measurement results from the measurement value of the first sample to the measurement value of a specified sample among the measurement values ​​of consecutively measured samples. Considering the accuracy of the approximation, it is desirable to have three or more samples, and similarly, it is advisable to specify the sample that is most susceptible to the deterioration of the ISE reagent. For example, in the case of Figure 6, if the rate of change is calculated as the slope obtained by first-order approximation of the 13 measurement results from the measurement value of the first sample to the measurement value of the 13th sample, the rate of change is 0.36.

[0045] S33: If the amount of variation found in step S32 is equal to or greater than predetermined value A (YES), it is determined that the ISE reagent has deteriorated, and that flow path maintenance is required before measuring the patient sample, and the process proceeds to step S34. On the other hand, if the amount of variation found in step S32 is less than predetermined value A (NO), the ISE reagent has not deteriorated, and the process proceeds to patient sample measurement (S06). The predetermined value A, which is the threshold for determination, is determined by the user based on the concentration of the flow path verification sample and the management level of each facility.

[0046] S34: Determine the level of deterioration of the ISE reagent. If the amount of variation calculated in step S32 is equal to or greater than predetermined value B (YES), the deterioration level of the ISE reagent is determined to be high, and the process proceeds to step S35. If the amount of variation is less than predetermined value B (NO), the deterioration level of the ISE reagent is determined to be low, and reagent priming is performed to replace the ISE reagent remaining in the flow path (S37). The predetermined value B, which is the threshold for determination, is set by the user at any value based on the concentration of the flow path verification sample and the management level of each facility. However, predetermined value B must be greater than predetermined value A.

[0047] S35: The cause of the high level of ISE reagent deterioration is estimated and the necessary maintenance is determined. As shown in the measurement results of Figures 3 to 6, the longer the waiting time, the more severe the reagent deterioration and the greater the fluctuation in the measurement value. On the other hand, if the ISE reagent is highly deteriorated despite a short waiting time, it is likely that dirt has accumulated in the ISE reagent flow path. If the waiting time is less than the predetermined time Y (YES), it is determined that dirt has accumulated in the ISE reagent flow path, and flow path cleaning with detergent is recommended (S36). If the waiting time is Y hours or more (NO), it is determined that deterioration has progressed due to the long waiting time, and reagent priming is performed (S37). The predetermined time Y, which is the threshold for judgment, is set by the user at an arbitrary value based on past ISE deterioration judgment results and the operation of each facility. However, the predetermined time Y is set to a value greater than the predetermined time X.

[0048] 11 is an example of a screen for determining the deterioration of an ISE reagent using the electrolyte analysis unit 8. The deterioration determination screen has a condition setting area 30 and a determination result display area 40.

[0049] In the condition setting area 30, the number of measurements of the flow path confirmation sample is set from the measurement number setting section 31, the name of the flow path confirmation sample is set from the flow path confirmation sample setting section 32, the type of fluctuation amount to be used for deterioration judgment is set from the fluctuation amount type setting section 33, the predetermined value A is set from the fluctuation amount predetermined value A setting section 34, the predetermined value B is set from the fluctuation amount predetermined value B setting section 35, and the predetermined time Y is set from the predetermined time setting section 36.

[0050] When the measurement of the flow path confirmation sample (S31) is performed, the measurement results are displayed in the judgment result display area 40. The predetermined time X display section 43 displays the predetermined time X applied to the current judgment, and the waiting time display section 44 displays the waiting time for the current measurement. The measurement result display section 41 displays the results of measuring the flow path confirmation sample set in the flow path confirmation sample setting section 32 the number of measurements set in the measurement count setting section 31. The amount of variation calculated in accordance with the measurement result and the type of variation set in the variation amount type setting section 33 is displayed in the variation amount display section 45, and recommended maintenance is displayed in the recommended maintenance display section 42.

[0051] In this way, in Example 1, if the waiting time exceeds a predetermined time, the electrolyte analyzer measures the flow path confirmation sample before measuring the patient sample, and the results are used to determine whether the ISE reagent has deteriorated. This eliminates measurement error due to deterioration of the ISE reagent in the flow path, improving the reliability of the measurement results. Furthermore, by determining whether maintenance is required for the ISE reagent flow path and, if necessary, notifying the user of the maintenance items to be performed, the time required for maintenance can be reduced.

[0052] In Example 1, the deterioration of the ISE reagent was determined by measuring the electrolyte concentration of the flow path verification sample using the ISE reagent. In Example 2, the deterioration of the remaining reagent was determined by measuring the concentration of interfering ions generated due to the deterioration of the ISE reagent remaining in the flow path using a colorimetric analysis unit. The disclosure of this example can be implemented with an automated analyzer that combines a colorimetric analysis unit and an electrolyte analysis unit, as shown in FIG. 1 . Examples 1 and 2 differ in the method of determining the deterioration of the remaining reagent, but are otherwise common. Therefore, in Example 2, the method of determining the deterioration of the remaining reagent will be described, and redundant explanations will be omitted. FIG. 12 is a flowchart for determining the deterioration of the remaining reagent according to Example 2. Step S41 corresponds to step S23 in the flow chart of FIG. 8, steps S42 to S45 correspond to step S24 in the flow chart of FIG. 8, and steps S46 to S47 correspond to step S25 in the flow chart of FIG. 8.

[0053] In the following explanation, the term "interfering ions" is used simply; however, when executing this flow, the interfering ions that arise due to deterioration of the ISE reagent and cause errors in the calculation of Cl ion concentration are identified, and the concentration of the identified interfering ions can be detected by colorimetric analysis.

[0054] S41: The diluted solution dispensed into the dilution tank 18 of the electrolyte analysis unit 8 is taken by the sample dispensing mechanism 7 and dispensed into the reaction vessel 5 of the colorimetric analysis unit. The reagent dispenser 6 takes an aliquot from a reagent bottle installed on the reagent disk 4 and dispenses it into the reaction vessel 5 from which the diluted solution was dispensed. The absorbance, which changes due to the reaction between the interfering ions in the diluted solution and the reagent, is measured by the photometer 13. The interfering ion concentration is calculated from the change in absorbance. This measurement is performed consecutively a predetermined number of times. The predetermined number of times is at least three or more and is determined by the user based on the type of fluctuation to be monitored and the model of the device.

[0055] S42: Calculate the amount of fluctuation in the concentration of interfering ions used to determine deterioration of the ISE reagent. As in Example 1, the amount of fluctuation can be the amount of change or rate of change in the measurement results of the concentration of interfering ions measured continuously.

[0056] S43: If the amount of variation found in step S42 is equal to or greater than the predetermined value A (YES), it is determined that the ISE reagent has deteriorated, and that flow path maintenance is required before measuring the patient sample, and the process proceeds to step S44. On the other hand, if the amount of variation found in step S42 is less than the predetermined value A (NO), the ISE reagent has not deteriorated, and the process proceeds to patient sample measurement (S06). The predetermined value A, which is the threshold for determination, is determined by the user at their own discretion based on the management level of each facility.

[0057] S44: Determine the level of deterioration of the ISE reagent. If the amount of variation calculated in step S42 is equal to or greater than predetermined value B (YES), the deterioration level of the ISE reagent is determined to be high, and the process proceeds to step S45. If the amount of variation is less than predetermined value B (NO), the deterioration level of the ISE reagent is determined to be low, and reagent priming is performed to replace the ISE reagent remaining in the flow path (S47). The predetermined value B, which is the threshold for determination, is set by the user at any value based on the management level of each facility. However, predetermined value B must be greater than predetermined value A.

[0058] S45: The cause of the high level of ISE reagent deterioration is estimated, and the necessary maintenance is determined. If the waiting time is less than the predetermined time Y hours (YES), it is determined that a factor causing rapid deterioration within a short period of time has occurred in the ISE reagent flow path, and cleaning of the flow path with detergent is recommended (S46). If the waiting time is Y hours or more (NO), it is determined that deterioration has progressed due to the long waiting time, and reagent priming is performed (S47). The predetermined time Y, which is the threshold for judgment, is set by the user at an arbitrary value based on past ISE deterioration judgment results and the operation of each facility. However, the predetermined time Y is set to a value greater than the predetermined time X.

[0059] 13 shows an example of a screen for determining deterioration of an ISE reagent using a colorimetric analysis unit. The deterioration determination screen has a condition setting area 50 and a determination result display area 60.

[0060] In the condition setting area 50, the number of measurements of the ISE reagent is set in the measurement count setting section 51, the name of the ISE reagent to be measured in the judgment target setting section 52, the type of fluctuation amount to be used for deterioration judgment in the fluctuation amount type setting section 53, the predetermined value A in the fluctuation amount predetermined value A setting section 54, the predetermined value B in the fluctuation amount predetermined value B setting section 55, and the predetermined time Y in the predetermined time setting section 56.

[0061] When the ISE reagent is measured (S41), the measurement results are displayed in the judgment result display area 60. The predetermined time X display section 63 displays the predetermined time X applied to the current judgment, and the waiting time display section 64 displays the waiting time for the current measurement. The measurement result display section 61 displays the results of measuring the ISE reagent set in the judgment target setting section 52 for the number of measurements set in the measurement count setting section 51. The variation amount calculated in accordance with the measurement result and the type of variation set in the variation amount type setting section 53 is displayed in the variation amount display section 65, and recommended maintenance is displayed in the recommended maintenance display section 62.

[0062] In this way, in Example 2, if the waiting time is longer than a predetermined time, the colorimetric analyzer measures the concentration of interfering ions contained in the diluent before measuring the patient sample, and the result is used to determine whether the diluent has deteriorated. This eliminates measurement error due to deterioration of the diluent in the flow path, thereby improving the reliability of the measurement results. In addition, the system determines whether maintenance is required for the ISE reagent flow path, and if necessary, notifies the user of the maintenance items to be performed, thereby reducing the time required to consider maintenance.

[0063] In Example 2, an example was shown in which the concentration of interfering ions contained in a dilution solution was measured, but the same applies to the internal standard solution. In addition, there are no restrictions on the type of interfering ions as long as they are ions that can be measured by the colorimetric analysis unit.

[0064] The present invention is not limited to the above-described embodiments and includes various modifications. For example, the above-described embodiments and modifications have been described in detail to make the present invention easier to understand, and are not necessarily limited to those including all of the described configurations. Furthermore, it is possible to replace part of the configuration of one embodiment or modification with the configuration of another embodiment or modification, and it is also possible to add the configuration of another embodiment or modification to the configuration of one embodiment or modification. Furthermore, it is possible to add, delete, or replace part of the configuration of each embodiment or modification with other configurations.

[0065] 1: Automatic analyzer, 2: Sample disk, 3: Sample cup, 4: Reagent disk, 5: Reaction vessel, 6: Reagent dispensing mechanism, 7: Sample dispensing mechanism, 8: Electrolyte analysis unit, 9: Interface, 10: Computer, 11: Printer, 12: Monitor, 13: Photometer, 14: Electrolyte concentration calculation unit, 15: Potentiometer, 16: Internal standard solution, 17: Dilution solution, 18: Dilution tank, 19: Cl ion electrode, 20: K ion electrode, 21: Na ion electrode, 22: Pinch valve, 23: Reference electrode, 24: Reference electrode solution, 25: Degassing tank , 26: Sipper syringe, 30, 50: Condition setting area, 31, 51: Measurement count setting section, 32: Flow path confirmation sample setting section, 33, 53: Fluctuation amount type setting section, 34, 54: Fluctuation amount predetermined value A setting section, 35, 55: Fluctuation amount predetermined value B setting section, 36, 56: Predetermined time setting section, 40, 60: Judgment result display area, 41, 61: Measurement result display section, 42, 62: Recommended maintenance display section, 43, 63: Predetermined time X display section, 44, 64: Waiting time display section, 45, 65: Fluctuation amount display section, 52: Judgment target setting section.

Claims

1. An automatic analyzer having an electrolyte analysis unit that measures electrolyte concentrations using an ion selective electrode method and is capable of measuring at least chloride ion concentration, and a control unit, wherein when the control unit receives a measurement instruction for a patient sample that requires measurement using the electrolyte analysis unit, if the standby time of the electrolyte analysis unit is equal to or longer than a predetermined time, the control unit determines whether a residual reagent remaining in a flow path of the electrolyte analysis unit has deteriorated prior to measuring the patient sample.

2. An automatic analyzer according to claim 1, wherein the electrolyte analysis unit comprises a dilution tank, an ion selective electrode, a comparison electrode, a flow path for discharging an internal standard solution into the dilution tank, a flow path for discharging the dilution solution into the dilution tank, a flow path for drawing the liquid in the dilution tank into the ion selective electrode, and a flow path for drawing the comparison electrode solution into the comparison electrode.

3. An automatic analyzer according to claim 1, wherein the control unit causes the electrolyte analysis unit to measure the chloride ion concentration of a flow path confirmation sample a predetermined number of times in succession, and determines the deterioration of the residual reagent based on the measurement results of the chloride ion concentration of the flow path confirmation sample.

4. An automatic analyzer according to claim 3, wherein the control unit measures the patient sample when the amount of fluctuation in the chloride ion concentration of the continuously measured flow path confirmation sample is less than a predetermined value, and when the amount of fluctuation is equal to or greater than the predetermined value, replaces residual reagent remaining in the flow path or recommends flow path maintenance.

5. An automatic analyzer according to claim 4, wherein the control unit calculates the amount of variation from the measurement values ​​of the flow path confirmation sample continuously measured, as the difference between the first measurement value and the measurement value of a designated number of measurements, or as the slope obtained by first-order approximation of the measurement values ​​from the first measurement value to the measurement value of the designated number of measurements.

6. An automatic analyzer according to claim 1, further comprising a colorimetric analysis unit capable of measuring the concentration of interfering ions that cause measurement errors in the chloride ion concentration in the electrolyte analysis unit, and the control unit causes the colorimetric analysis unit to measure the interfering ion concentration of the residual reagent a predetermined number of times in succession, and determines whether the residual reagent has deteriorated based on the measurement results of the interfering ion concentration of the residual reagent.

7. An automatic analyzer as claimed in claim 6, wherein the control unit measures the patient sample when the amount of fluctuation in the interfering ion concentration of the residual reagent measured continuously is less than a predetermined value, and when the amount of fluctuation is equal to or greater than the predetermined value, replaces the residual reagent remaining in the flow path or recommends maintenance of the flow path.

8. An automatic analyzer according to claim 7, wherein the control unit calculates the amount of variation from the measurement value of the residual reagent continuously measured as the difference between the first measurement value and the measurement value after a designated number of measurements, or as the slope obtained by first-order approximation of the measurement values ​​from the first measurement value to the measurement value after the designated number of measurements.

9. A method for measuring a patient sample using an automatic analyzer comprising an electrolyte analysis unit capable of measuring electrolyte concentration by ion selective electrode method and at least chloride ion concentration, and a control unit, wherein the control unit measures a standby time of the electrolyte analysis unit when it receives a measurement instruction for the patient sample that requires measurement using the electrolyte analysis unit, and when the standby time of the electrolyte analysis unit is equal to or longer than a predetermined time, the control unit determines deterioration of a residual reagent remaining in a flow path of the electrolyte analysis unit prior to measuring the patient sample.

10. A measurement method as claimed in claim 9, wherein the electrolyte analysis unit measures the chloride ion concentration of the flow path confirmation sample a predetermined number of times in succession, and the control unit determines the deterioration of the residual reagent based on the measurement results of the chloride ion concentration of the flow path confirmation sample.

11. A measurement method as claimed in claim 10, wherein the control unit measures the patient sample when the amount of fluctuation in the chloride ion concentration of the continuously measured flow path confirmation sample is less than a predetermined value, and when the amount of fluctuation is equal to or greater than the predetermined value, replaces residual reagent remaining in the flow path or recommends flow path maintenance.

12. A measurement method as set forth in claim 11, wherein the control unit calculates the amount of variation from the measurement values ​​of the flow path confirmation sample that are continuously measured, as the difference between the first measurement value and the measurement value of a designated number of measurements, or as the slope obtained by first-order approximation of the measurement values ​​from the first measurement value to the measurement value of the designated number of measurements.

13. A measurement method as claimed in claim 9, wherein the automatic analysis device is provided with a colorimetric analysis unit capable of measuring the concentration of interfering ions that cause measurement errors in the chloride ion concentration in the electrolyte analysis unit, the colorimetric analysis unit continuously measures the interfering ion concentration of the residual reagent a predetermined number of times, and the control unit determines deterioration of the residual reagent based on the measurement results of the interfering ion concentration of the residual reagent.

14. A measurement method as claimed in claim 13, wherein the control unit measures the patient sample when the amount of fluctuation in the interfering ion concentration of the residual reagent measured continuously is less than a predetermined value, and when the amount of fluctuation is equal to or greater than the predetermined value, replaces the residual reagent remaining in the flow path or recommends maintenance of the flow path.

15. A measurement method as set forth in claim 14, wherein the control unit calculates the amount of variation from the measurement value of the residual reagent continuously measured as the difference between the first measurement value and the measurement value after a designated number of measurements, or as the slope obtained by first-order approximation of the measurement values ​​from the first measurement value to the measurement value after the designated number of measurements.

Citation Information

Patent Citations

  • Clinical electrolyte measuring instrument

    JP1996035944A

  • Abnormality cause estimation method, analysis system, and information management server device

    JP2010266271A

  • Management system of electrolyte analyzer

    JP2013213841A

  • Automated analysis device

    WO2022270044A1